Ophthotech reported $331.79M in Assets for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Alimera Sciences ALIM:US USD 43.43M 4.14M
Bioline Rx BLRX:US USD 81.67M 13.84M
Cytrx CYTR:US USD 6.56M 2.16M
Insmed INSM:US USD 1.66B 661.62M
Nektar Therapeutics NKTR:US USD 710.6M 70.41M
Novartis NOVN:VX USD 117.45B 1.01B
Regeneron Pharmaceuticals REGN:US USD 29.21B 1.54B
Roche Holding ROG:VX 88.15B 1.42B